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Myelin basic protein kinase (MBPK) activity of rat adipocytes was measured irectly or in gels after purification of p42 microtubule-associated 
protein kinase (MAPK). Insulin and phorbol esters provoked 2- to 3-fold increases in MBPWMAPK activity within 5-10 min. Whereas phorbol 
ester effects were blocked by protein kinase C (PKC) depletion or inhibition, insulin effects were fully intact, indicating that insulin activates 
MBPK/MAPK independently of PKC. In contrast, PKC depletion or inhibition markedly inhibited insulin effects on [-‘H]2-deoxyglucose uptake, 
suggesting that this effect requires PKC, rather than a factor within the ras/MAPK cascade. 
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1. INTRODUCTION 
Insulin activates serine/threonine PK, including 
MAPK [l] and PKC [2,3] in rat adipocytes. Frequently, 
these PK pathways are interdependent, e.g. phorbol es- 
ters may activate MAPK via PKC-mediated activation 
of rus or a PK upstream of MAPK [4,5], or, rus may 
activate phosphatidyicholine hydrolysis [6,7] and thus 
PKC. Studies in NIH3T3 cells suggest hat insulin acti- 
vates the radMAPK pathway independently of PKC 
[S], but, it is uncertain if insulin activates PKC signifi- 
cantly in these cells. Since insulin translocates or acti- 
vates PKC in rat adipocytes [2,3,9,10], we questioned 
whether insulin effects on MAPK were sensitive to PKC 
depletion or inhibition in these cells. This question 
seemed important since hexose uptake in rat adipocytes 
is stimulated by activation of PKC and/or other serine/ 
threonine protein kinases [1 l-141, is inhibited by PKC 
depletion [ 12,131 and PKC inhibitors [ 15,161, and is res- 
cued by electroporation of purified PKC into PKC- 
depleted adipocytes [171. 
2. EXPERIME~AL 
As described [2,13], adipocytes were prepared from epididymal fat 
pads of 200 g male Holtzman rats, equilibrated in glucose-free Krebs- 
Ringer phosphate (KRP) buffer containing 1% BSA, and treated with 
or without insulin (Elanco) or tetradecanoyl phorbol-13-acetate (TPA; 
Sigma). After incubation, adipocytes were sonicated in buffer contain- 
ing 40 mM b-glycerophosphate (pH 7.3), 0.5 mM dithiothreitol, 0.75 
mM EGTA, 0.15 mM sodium vanadate, 5 &ml leupeptin, 0.1 mM 
PMSF, 5 &ml trypsin inhibitor and 5 @ml aprotonin, as described 
[I]. Cytosolic extracts were obtained by centrifugation for 30 min at 
100,000 x g and directly assayed for MBPK activity, (see [I]), or after 
SDS-PAGE in MBP-containing gels (see [18]). In the direct MBPK 
assay, 5 pg cytosolic protein was incubated at 30°C for 10 min in 50 
.ul buffer containing 25 mM ~-gly~rophosphate @H, 7.3), 0.5 mM 
dithiothreitol, 1.25 mM EGTA, 0.5 mM sodium vanadate, 10 mM 
MgCl,, 1 mg/ml BSA, 1 PM okadaic acid, and 0.1 mM [y-‘*P]ATP 
(NEN; sp. act. l,SOO,OOO dpmfnmol), with or without 50 pg MBP 
(Sigma) (see [l]). After incubation, aliquots of reaction mixtures were 
applied to P81 Whatman filter paper, washed with 1% phosphoric 
acid, and counted for radioacti~ty. Labelling observed in the absence 
of MBP was subtracted from that observed in the presence of MBP 
In the MBPcontaining gel assay, cytosolic extracts were subjected to 
SDS-PAGE in gels ~nt~nin~O.S% MBP, and, after denaturation and 
subsequent renaturation of the gels, MBPK activity was measured in 
the presence of [y-32P]ATP and 10 mM MgCl, (see [18]). The gels were 
analyzed by autoradiography and laser densitomet~ scanning for 
determination of MBPK activity of 42 and 45 kDa proteins, i.e. p42/45 
MAP kinases [18,19], or ERK-2/ERK-1. In some experiments, adi- 
pocytes were cultured overnight in the Dulbecco’s Modified Eagles 
Medium (DMEM) containing 1% BSA with or without 1 ,uM TPA, 
as described [13,17,20]. These ‘TPA-downregulated’ adipocytes are 
partially depleted (5080%) of PKC enzyme activity and PKC 
isoforms, a, /?, y, 6 and c, but there are no changes in insulin receptor 
binding and tyrosine kinase activities [12,13,17,20]. In some experi- 
ments, bisindolylmaleimide (Calbi~hem) was used as a PKC inhibitor 
(see [21]). The uptake of [-‘H]Z-deoxyglucose [3H]2-DOG) was deter- 
mined, as described [13,17]. 
3. RESULTS 
*Cor~ponding author. 
Insulin-induced increases in cytosolic MBPK activity 
were maximal (Zfold) at 10 minutes and decreased at 
later times: in comparison, TPA provoked 2- to 3-fold 
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Fig. 1. Time-dependent effects of insulin (10 nM, 0) and TPA (500 nM, 
o) treatment on MBPK activity in rat adipocytes. Cytosolic fractions 
were assayed for MBPK activity directly (Panel A), or after SDS- 
PAGE in MBP-containing gels (Panel B). Panel A shows mean 
(+ SE.) values of 3 experiments. Panel B portrays a representative 
autoradiogram of MBP labeling by p42145 MAPK (in most experi- 
ments, only p42 MAPK was apparent). Note that the control (0 min) 
is shown in the center of the autoradiogram. 
increases at 5 min and these were more persistant (Fig. 
1). As in other studies [18,19], increases in cytosolic 
MBPK activity observed in the direct assay were reflec- 
tive (albeit not solely) of p42/45 MAPK activation, as 
shown in MBP-containing gel assays (Figs. l-3). In four 
experiments, the mean (& S.E.) insulin-induced increase 
in p42 MAPK activity (as per gel assay) was 68 + 8% 
(P < 0.005; paired t-test). 
As in previous studies [12,13,17,20], overnight TPA- 
pretreatment diminished PKC (not shown) and 
downregulated both insulin- and TPA-stimulated, but 
not basal, hexose transport (Fig. 2). In contrast, in these 
downregulated adipocytes, insulin provoked 2-fold in- 
creases in cytosolic MBPWMAPK activity, as meas- 
ured in direct and gel assays (Fig. 2). In three separate 
experiments, insulin effects on MBPK/MAPK kinase 
were virtually the same in downregulated and non- 
dowmegulated cells. In contrast, TPA-induced activa- 
tion of MBPK was blocked in PKC-downregulated ad- 
ipocytes (Fig. 2). Note that basal MBPK/MAPK activ- 
ity was not altered significantly by overnight TPA pre- 
treatment. 
As a PKC inhibitor [21], 1OO~M bisindolylmaleimide 
(BIM), markedly inhibited insulin-stimulated hexose 
uptake and TPA-stimulated MBPK, but only mildly 
(20-30%) inhibited basal MBPK, and had no effect on 
insulin-induced activation of MBPWMAPK (Fig. 3). If 
288 
anything, insulin effects on MBP/MAPK were more 
prolonged by BIM. 
4. DISCUSSION 
As in NIH3T3 cells [8,22], insulin activated MAPK 
in rat adipocytes independently of PKC. This conclu- 
A. 
S 
t, 
S- 
I! 
.E 
$3 
s 
‘S 
P’ 
J 
0. 
0 10 20 30 & 
Insulin, mln TPA, 10 min 
f- non-downregulated , t- TPA-downregulated --, 
p42 -_) 
f&N Ins RX: 0 5 10 2030 0 5 10 20 30 
c. 
non-darnr.gulm1.d TPA- downropulaiad 
Fig. 2. Effects of TPA-induced downregulation of PKC on insulin- or 
TPA-induced activation of MBPK/MAPK (Panels A and B) and 
[~HjZdeoxyglucose uptake (Panel C) in rat adipocytes. Cells were 
cultured overnight with ~TPA-do~regulate~) or without (‘non- 
downregulated’) 1 FM TPA, washed, equilibrated in glucose-free KRP 
medium and treated without or with 10 nM insulin or 500 nM TPA 
for the indicated times. Cytosolic fractions were assayed for MBPK 
activity directly (Panel A) or after SDS-PAGE in MBP-containing gels 
(Panel B). Results at the left (a) of Panel A are expressed as the percent 
of the control (closed circles, TPA-downregulated cells; open squares, 
non-downregulated cells). Results at the right (b) of Panel A are 
expressed as the percent increase due to acute lo-min TPA treatment 
over the non-downregulated (open bar) or the TPA~ownregulat~ 
(solid bar) control. (Note: overnight TPA pre-treatment did not alter 
basal MBPK or p42MAPK activity.) Panel B shows autoradiographic 
results of insulin effects on p42 MAPK in non-downregulat~ (left) or 
TPA-downregulated (right) cells. Pancel C shows acute effects of insu- 
lin (hatched bars). TPA (solid bars), or vehicle alone (controls, open 
bars) on ~3H]2~eoxyglu~se uptake in non-downregulat~ (left) and 
TPA-downregulated (right) cultured cells. Values are mean + SE. of 
4 determinations. Comparable result were observed in 3 experiments. 
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Fig. 3. Effects of bisindolylm~eimide (BIM) on insulin- or TPA- 
induced activation of MBPKlMAPK and [3H]2-deoxyglucose uptake 
in rat adipocytes. Cells were treated for 10 min with 100 PM BIM in 
0.5% DMSO (solid circles and bars), or with 0.5% DMSO alone (open 
squares and bars), and then treated with 10 nM insulin or 500 nM TPA 
for times indicated in Panels A and B. Cytosolic extracts were assayed 
for MBPK activity directly (Panel A) or after SDS-PAGE in MBP- 
containing gels (Panel B). Panel C shows dose-related inhibitory ef- 
fects (mean values + SE. of 4 determinations) of BIM on insulin- 
stimulate [3~2~eoxygluco~ uptake (0) in intact adipocytes, and in 
vitro MBPK activity (0) of TPA-stimulated cytosol. Comparable re- 
sults were in repeat experiments. 
sion seems clear, since insulin-induced activation of 
MAPK was ftily intact in adipocytes that were fimc- 
tionally deficient in PKC, due to either TPA-induced 
PKC depletion or BIM-induced PKC inhibition. Thus, 
although PKC may be activated by insulin in rat adi- 
pocytes (see [2,3,9,10]), this is clearly not necessary for 
insulin-induced activation of MAPK. Further, if insulin 
activates MAPK via PKC, this would appear to be a 
redundant mech~ism. 
That insulin fully activated MAPK in PKC-depleted 
and PKC-inhibited adipocytes indicates that all relevant 
steps proximal to MAPK were functionally intact, pre- 
sumably including the activation of insulin receptor ty- 
rosine kinase, rus, and intervening PK’s that precede 
MAPK (see [ 1,4,5,8,22]). These findings complement 
previous studies in which insulin re~ptor-de~ndent 
insulin-binding and tyrosine kinase activities were not 
altered by TPA-induced PKC depletion in rat adi- 
pocytes [ 131. 
Of note, hexose transport effects of insulin were 
markedly compromised by PKC depletion and inhibi- 
tion, despite full activation of MBPKIMAPK. Thus, 
insulin-stimulated hexose uptake seems to require PKC 
or a related factor extrinsic to the ra.s/MAPK pathway. 
A similar conclusion was reached by Osterof et al. [23], 
who found that dominant positive or negative mutant- 
induced alterations in ras activity had little or no effect 
on the activation of hexose transport by insulin in 
NIH3T3 cells, CHO cells, and rat-l fibroblasts. On the 
other hand, the ras/MAPK pathway seems to play an 
important role in insulin-regulated gene expression and 
cellular proliferation [24]. 
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